Chemomab Therapeutics (CMMB) Cash & Equivalents Growth (3y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - | -17.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.60% |
| Sep 30, 2025 | -13.61% |
| Jun 30, 2025 | -17.27% |
| Mar 31, 2025 | -15.52% |
| Dec 31, 2024 | -26.33% |
| Sep 30, 2024 | -44.08% |
| Jun 30, 2024 | -51.72% |
| Mar 31, 2024 | -56.88% |
| Dec 31, 2023 | -7.32% |
| Sep 30, 2023 | 10.60% |
| Jun 30, 2023 | 5.57% |
| Mar 31, 2023 | 14.02% |
| Dec 31, 2022 | -8.37% |
| Sep 30, 2022 | -22.50% |
| Jun 30, 2022 | -28.47% |
| Mar 31, 2022 | -24.50% |
| Dec 31, 2021 | 26.42% |
| Sep 30, 2021 | 196.09% |
| Jun 30, 2021 | 214.88% |
| Dec 31, 2020 | 100.24% |